Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity. / Dall, Morten; Trammell, Samuel A. J.; Asping, Magnus; Hassing, Anna S; Agerholm, Marianne; Vienberg, Sara G; Gillum, Matthew P; Larsen, Steen; Treebak, Jonas T.

In: The Journal of Biological Chemistry, Vol. 294, No. 36, 2019, p. 13304-13326.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Dall, M, Trammell, SAJ, Asping, M, Hassing, AS, Agerholm, M, Vienberg, SG, Gillum, MP, Larsen, S & Treebak, JT 2019, 'Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity', The Journal of Biological Chemistry, vol. 294, no. 36, pp. 13304-13326. https://doi.org/10.1074/jbc.RA118.006756

APA

Dall, M., Trammell, S. A. J., Asping, M., Hassing, A. S., Agerholm, M., Vienberg, S. G., Gillum, M. P., Larsen, S., & Treebak, J. T. (2019). Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity. The Journal of Biological Chemistry, 294(36), 13304-13326. https://doi.org/10.1074/jbc.RA118.006756

Vancouver

Dall M, Trammell SAJ, Asping M, Hassing AS, Agerholm M, Vienberg SG et al. Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity. The Journal of Biological Chemistry. 2019;294(36):13304-13326. https://doi.org/10.1074/jbc.RA118.006756

Author

Dall, Morten ; Trammell, Samuel A. J. ; Asping, Magnus ; Hassing, Anna S ; Agerholm, Marianne ; Vienberg, Sara G ; Gillum, Matthew P ; Larsen, Steen ; Treebak, Jonas T. / Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity. In: The Journal of Biological Chemistry. 2019 ; Vol. 294, No. 36. pp. 13304-13326.

Bibtex

@article{9652366a5b7b47edb9f64632f07430f2,
title = "Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity",
abstract = "Supplementation with NAD precursors such as nicotinamide riboside (NR) has been shown to enhance mitochondrial function in the liver and to prevent hepatic lipid accumulation in high-fat diet (HFD)-fed rodents. Hepatocyte-specific knockout of the NAD+-synthesizing enzyme nicotinamide phosphoribosyltransferase (NAMPT) reduces liver NAD+ levels, but the metabolic phenotype of Nampt-deficient hepatocytes in mice is unknown. Here, we assessed Nampt's role in maintaining mitochondrial and metabolic functions in the mouse liver. Using the Cre-LoxP system, we generated hepatocyte-specific Nampt knockout (HNKO) mice, having a 50% reduction of liver NAD+ levels. We screened the HNKO mice for signs of metabolic dysfunction following 60% HFD feeding for 20 weeks ± NR supplementation and found that NR increases hepatic NAD+ levels without affecting fat mass or glucose tolerance in HNKO or WT animals. High-resolution respirometry revealed that NR supplementation of the HNKO mice did not increase state III respiration, which was observed in WT mice following NR supplementation. Mitochondrial oxygen consumption and fatty-acid oxidation were unaltered in primary HNKO hepatocytes. Mitochondria isolated from whole-HNKO livers had only a 20% reduction in NAD+, suggesting that the mitochondrial NAD+ pool is less affected by HNKO than the whole-tissue pool. When stimulated with tryptophan in the presence of [15N]glutamine, HNKO hepatocytes had a higher [15N]NAD+ enrichment than WT hepatocytes, indicating that HNKO mice compensate through de novo NAD+ synthesis. We conclude that NAMPT-deficient hepatocytes can maintain substantial NAD+ levels and that the Nampt knockout has only minor consequences for mitochondrial function in the mouse liver.",
author = "Morten Dall and Trammell, {Samuel A. J.} and Magnus Asping and Hassing, {Anna S} and Marianne Agerholm and Vienberg, {Sara G} and Gillum, {Matthew P} and Steen Larsen and Treebak, {Jonas T.}",
note = "{\textcopyright} 2019 Dall et al.",
year = "2019",
doi = "10.1074/jbc.RA118.006756",
language = "English",
volume = "294",
pages = "13304--13326",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology, Inc.",
number = "36",

}

RIS

TY - JOUR

T1 - Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity

AU - Dall, Morten

AU - Trammell, Samuel A. J.

AU - Asping, Magnus

AU - Hassing, Anna S

AU - Agerholm, Marianne

AU - Vienberg, Sara G

AU - Gillum, Matthew P

AU - Larsen, Steen

AU - Treebak, Jonas T.

N1 - © 2019 Dall et al.

PY - 2019

Y1 - 2019

N2 - Supplementation with NAD precursors such as nicotinamide riboside (NR) has been shown to enhance mitochondrial function in the liver and to prevent hepatic lipid accumulation in high-fat diet (HFD)-fed rodents. Hepatocyte-specific knockout of the NAD+-synthesizing enzyme nicotinamide phosphoribosyltransferase (NAMPT) reduces liver NAD+ levels, but the metabolic phenotype of Nampt-deficient hepatocytes in mice is unknown. Here, we assessed Nampt's role in maintaining mitochondrial and metabolic functions in the mouse liver. Using the Cre-LoxP system, we generated hepatocyte-specific Nampt knockout (HNKO) mice, having a 50% reduction of liver NAD+ levels. We screened the HNKO mice for signs of metabolic dysfunction following 60% HFD feeding for 20 weeks ± NR supplementation and found that NR increases hepatic NAD+ levels without affecting fat mass or glucose tolerance in HNKO or WT animals. High-resolution respirometry revealed that NR supplementation of the HNKO mice did not increase state III respiration, which was observed in WT mice following NR supplementation. Mitochondrial oxygen consumption and fatty-acid oxidation were unaltered in primary HNKO hepatocytes. Mitochondria isolated from whole-HNKO livers had only a 20% reduction in NAD+, suggesting that the mitochondrial NAD+ pool is less affected by HNKO than the whole-tissue pool. When stimulated with tryptophan in the presence of [15N]glutamine, HNKO hepatocytes had a higher [15N]NAD+ enrichment than WT hepatocytes, indicating that HNKO mice compensate through de novo NAD+ synthesis. We conclude that NAMPT-deficient hepatocytes can maintain substantial NAD+ levels and that the Nampt knockout has only minor consequences for mitochondrial function in the mouse liver.

AB - Supplementation with NAD precursors such as nicotinamide riboside (NR) has been shown to enhance mitochondrial function in the liver and to prevent hepatic lipid accumulation in high-fat diet (HFD)-fed rodents. Hepatocyte-specific knockout of the NAD+-synthesizing enzyme nicotinamide phosphoribosyltransferase (NAMPT) reduces liver NAD+ levels, but the metabolic phenotype of Nampt-deficient hepatocytes in mice is unknown. Here, we assessed Nampt's role in maintaining mitochondrial and metabolic functions in the mouse liver. Using the Cre-LoxP system, we generated hepatocyte-specific Nampt knockout (HNKO) mice, having a 50% reduction of liver NAD+ levels. We screened the HNKO mice for signs of metabolic dysfunction following 60% HFD feeding for 20 weeks ± NR supplementation and found that NR increases hepatic NAD+ levels without affecting fat mass or glucose tolerance in HNKO or WT animals. High-resolution respirometry revealed that NR supplementation of the HNKO mice did not increase state III respiration, which was observed in WT mice following NR supplementation. Mitochondrial oxygen consumption and fatty-acid oxidation were unaltered in primary HNKO hepatocytes. Mitochondria isolated from whole-HNKO livers had only a 20% reduction in NAD+, suggesting that the mitochondrial NAD+ pool is less affected by HNKO than the whole-tissue pool. When stimulated with tryptophan in the presence of [15N]glutamine, HNKO hepatocytes had a higher [15N]NAD+ enrichment than WT hepatocytes, indicating that HNKO mice compensate through de novo NAD+ synthesis. We conclude that NAMPT-deficient hepatocytes can maintain substantial NAD+ levels and that the Nampt knockout has only minor consequences for mitochondrial function in the mouse liver.

U2 - 10.1074/jbc.RA118.006756

DO - 10.1074/jbc.RA118.006756

M3 - Journal article

C2 - 31320478

VL - 294

SP - 13304

EP - 13326

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 36

ER -

ID: 227417862